DEL MAR, Calif., Dec. 8 /PRNewswire-FirstCall/ -- American Diversified Holdings Corporation (Pink Sheets: ADHC) has announced, as part of its previously disclosed strategy to concentrate in developing innovative technologies in the life sciences sector, specifically targeting the fast growing stem cell arena, that the Company is actively seeking to acquire stem cell patents for the express purpose of developing these patents for commercial purposes.
The initial thrust of the program is to solicit from the country's leading companies and research institutions in this area and seek submission from them of intellectual properties for consideration of investment by ADHC.
Inquiries regarding these properties should be submitted directly to the Company's CEO, Ernest B. Remo, via the Company's website address: [email protected], where all inquiries will be dealt with promptly and confidentially.
About American Diversified Holdings Corporation
(www.americandiversifiedholdings.com)
American Diversified Holdings Corporation is a publicly traded holding company headquartered in Del Mar, California engaged in developing innovative technologies in the life sciences sector with the primary emphasis in the stem cell arena. The enterprise was formed for the express purpose of investing in and acquiring stem cell related intellectual property and companies.
This press release contains forward-looking statements pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. This press release in no way constitutes any recommendation regarding the securities of ADHC or its affiliates. Any person reading this release is advised that this release should be considered in the light of all facts and circumstances regarding the business and financial condition and prospects of ADHC, and no inference has been made that this release contains all such information
SOURCE American Diversified Holdings Corporation
